126 related articles for article (PubMed ID: 28593532)
1. Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China.
Si L; Shi L; Chen M; Palmer AJ
Qual Life Res; 2017 Nov; 26(11):3049-3058. PubMed ID: 28593532
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Association Between Health State Utilities and Obesity in Sub-Saharan Africa: Evidence From World Health Organization Study on Global AGEing and Adult Health Wave 2.
Lartey ST; Si L; de Graaff B; Magnussen CG; Ahmad H; Campbell J; Biritwum RB; Minicuci N; Kowal P; Palmer AJ
Value Health; 2019 Sep; 22(9):1042-1049. PubMed ID: 31511181
[TBL] [Abstract][Full Text] [Related]
3. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
Orji NC; Cox IA; Jason LA; Chen G; Zhao T; Rogerson MJ; Kelly RM; Wills K; Hensher M; Palmer AJ; de Graaff B; Campbell JA
Qual Life Res; 2024 Jan; 33(1):45-57. PubMed ID: 37561337
[TBL] [Abstract][Full Text] [Related]
4. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.
Liu L; Li S; Zhao Y; Zhang J; Chen G
Qual Life Res; 2018 May; 27(5):1323-1333. PubMed ID: 29492743
[TBL] [Abstract][Full Text] [Related]
5. Population norms for the EQ-5D-3L in China derived from the 2013 National Health Services Survey.
Yao Q; Liu C; Zhang Y; Xu L
J Glob Health; 2021 Feb; 11():08001. PubMed ID: 33692898
[TBL] [Abstract][Full Text] [Related]
6. EQ-5D-3L as a health measure of Brazilian adult population.
Menezes Rde M; Andrade MV; Noronha KV; Kind P
Qual Life Res; 2015 Nov; 24(11):2761-76. PubMed ID: 25896666
[TBL] [Abstract][Full Text] [Related]
7. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
8. Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Hakimi Z; Herdman M; Pavesi M; Devlin N; Nazir J; Hoyle C; Odeyemi IA
Qual Life Res; 2017 May; 26(5):1187-1195. PubMed ID: 27896711
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
10. The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.
Ul Husnain MI; Hajizadeh M; Ahmad H; Khanam R
Appl Health Econ Health Policy; 2024 Jul; 22(4):583-598. PubMed ID: 38530626
[TBL] [Abstract][Full Text] [Related]
11. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
12. Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians.
Singh A; Campbell JA; Venn A; Jones G; Blizzard L; Palmer AJ; Dwyer T; Cicuttini F; Ding C; Antony B
Qual Life Res; 2021 Sep; 30(9):2601-2613. PubMed ID: 33942204
[TBL] [Abstract][Full Text] [Related]
13. Patient versus general population health state valuations: a case study of non-specific low back pain.
van Dongen JM; van denBerg B; Bekkering GE; van Tulder MW; Ostelo RWJG
Qual Life Res; 2017 Jun; 26(6):1627-1633. PubMed ID: 28155048
[TBL] [Abstract][Full Text] [Related]
14. Chinese time trade-off values for EQ-5D health states.
Liu GG; Wu H; Li M; Gao C; Luo N
Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
[TBL] [Abstract][Full Text] [Related]
15. Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China.
Jin X; Liu GG; Gerstein HC; Levine MAH; Guan H; Li H; Xie F
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3053. PubMed ID: 30064154
[TBL] [Abstract][Full Text] [Related]
16. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
[TBL] [Abstract][Full Text] [Related]
17. Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China.
Yu H; Zhang H; Yang J; Liu C; Lu C; Yang H; Huang W; Zhou J; Fu W; Shi L; Yan Y; Liu G; Li L
BMC Cancer; 2018 Oct; 18(1):950. PubMed ID: 30285666
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
Couzner L; Crotty M; Norman R; Ratcliffe J
Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
[TBL] [Abstract][Full Text] [Related]
19. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach.
Pullenayegum EM; Chan KK; Xie F
Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449
[TBL] [Abstract][Full Text] [Related]
20. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
